Skip to main content
. 2022 Apr 26;16(5):906–915. doi: 10.1111/irv.12994

TABLE 2.

MRU during hospitalization (substudy)

CRFs a No CRFs
Influenza (n = 153) RSV (n = 99) Influenza (n = 25) RSV (n = 13)
Length of hospital stay, b mean (SD), days 4.7 (3.0) c 5.4 (3.1) d 4.8 (4.6) 6.7 (10.1)
Median (range), days 4 (1, 18) 4.5 (2, 17) 3 (2, 21) 3 (1, 38)
≤3 days, n (%) 67 (43.8) 30 (30.3) 13 (52.0) 7 (53.8)
>3 days, n (%) 86 (56.2) 69 (69.7) 12 (48.0) 6 (46.2)
O2 supplementation given, n (%) 91 (59.5) 79 (79.8) 13 (52.0) 7 (53.8)
O2 supplementation duration, mean (SD), days 4.5 (3.6) e 4.2 (2.8) f 4.1 (4.3) g 4.2 (4.6) h
Mechanical ventilation given, n (%) 3 (2.0) 0 (0) 0 (0) 0 (0)
ICU stay during hospitalization, n (%) 8 (5.2) 8 (8.1) 1 (4.0) 1 (7.7)
ICU stay duration, mean (SD), days 4.8 (1.3) 2.5 (1.0) i 3.0 (−) 4.0 (−)
ICU stay duration, median (range), days 4.5 (3, 7) 2 (2, 4) i 3 (3, 3) 4 (4, 4)

Abbreviations: COPD, chronic obstructive pulmonary disease; CRF, core risk factor; ICU, intensive care unit; MRU, medical resource utilization; RSV, respiratory syncytial virus; SD, standard deviation.

a

CRFs included any one or a combination of the following: age ≥65 years, chronic heart disease, COPD, chronic renal disease, and asthma.

b

Data from four subjects with censored length of hospital stay data not included in mean (SD) and median (range) results. Censored data included three patients with influenza and CRFs (>2, >3, and >6 days) and one patient with RSV and CRFs (<3 days).

c

Data available for 150/153 patients.

d

Data available for 98/99 patients.

e

Data available for 82/91 patients given supplemental oxygen.

f

Data available for 73/79 patients given supplemental oxygen.

g

Data available for 13/13 patients given supplemental oxygen.

h

Data available for 6/7 patients given supplemental oxygen.

i

Data available for 4/8 patients with ICU stays during hospitalization.